HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by Krein, P. M. Articles by Winston, B. W. Search for Related Content PubMed PubMed Citation Articles by Krein, P. M. Articles by Winston, B. W.

Roles for Insulin-Like Growth Factor I and Transforming Growth Factor-ß in Fibrotic Lung Disease^*

^* From the Immunology Research Group, University of Calgary, Calgary, AB, Canada.

Correspondence to: Brent W. Winston, MD, FCCP, Departments of Medicine, Biochemistry and Molecular Biology, and Critical Care Medicine, University of Calgary, Health Sciences Center, Room 1843, 3330 Hospital Dr NW, Calgary, AB, Canada, T2N 4N1; e-mail: bwinston{at}ucalgary.ca

Idiopathic pulmonary fibrosis (IPF) is a lung disease that is characterized by epithelial cell damage and areas of denuded basement membrane resulting in inflammation, fibroblast proliferation, excessive extracellular matrix (ECM) deposition, and remodeling of alveolar gas exchange units. The progressive loss of lung gas exchange units in patients with IPF leads to respiratory failure and eventually to death. While the etiology of this disease is unknown, for many years studies suggested that chronic inflammation was the underlying factor that caused fibroproliferation and structural alterations of the lung. Recent data show that fibroproliferation and fibrosis can occur independently of inflammation, suggesting that IPF is a disease caused by a mesenchymal, rather than an immune disorder. Mesenchymal growth factors, including transforming growth factor (TGF)-ß, insulin-like growth factor (IGF)-I, platelet-derived growth factor, connective tissue growth factor, fibroblast growth factors, and keratinocyte growth factors, as well as proinflammatory cytokines such as tumor necrosis factor- and interleukin-1ß, have been shown to be exaggerated in several fibrotic lung disorders including IPF, ARDS, sarcoidosis, and bronchopulmonary dysplasia, as well as pulmonary manifestations of systemic diseases such as rheumatoid arthritis or progressive systemic sclerosis (scleroderma). We argue that inflammation is required to initiate growth factor production and repair of the damaged alveolar epithelial lining in fibrotic lung diseases and that exaggerated TGF-ß production may be responsible for the fibrotic response seen in diseases such as IPF. We recognize the potential role of several growth factors in the fibroproliferative process in the lung, and in this brief report we focus on the possible roles of the growth factors IGF-I and TGF-ß in cell migration, proliferation, and ECM synthesis in patients with IPF.

Key Words: fibroproliferation • insulin-like growth factor-I • pulmonary fibrosis • transforming growth factor-ß

This article has been cited by other articles:

				Y. Q. Xiao, C. G. Freire-de-Lima, W. J. Janssen, K. Morimoto, D. Lyu, D. L. Bratton, and P. M. Henson Oxidants Selectively Reverse TGF-{beta} Suppression of Proinflammatory Mediator Production J. Immunol., January 15, 2006; 176(2): 1209 - 1217. [Abstract] [Full Text] [PDF]

				A. Azuma, Y. J. Li, S. Abe, J. Usuki, K. Matsuda, S. Henmi, Y. Miyauchi, K. Ueda, A. Izawa, S. Sone, et al. Interferon-{beta} Inhibits Bleomycin-Induced Lung Fibrosis by Decreasing Transforming Growth Factor-{beta} and Thrombospondin Am. J. Respir. Cell Mol. Biol., February 1, 2005; 32(2): 93 - 98. [Abstract] [Full Text] [PDF]

				A. Hartnell, A. Heinemann, D. M. Conroy, R. Wait, G. J. Sturm, M. Caversaccio, P. J. Jose, and T. J. Williams Identification of Selective Basophil Chemoattractants in Human Nasal Polyps as Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-2 J. Immunol., November 15, 2004; 173(10): 6448 - 6457. [Abstract] [Full Text] [PDF]